An international study of intrachromosomal amplification of chromosome 21 (iAMP21): Cytogenetic characterization and outcome

Leukemia

Volumn 28, Issue 5, 2014, Pages 1015-1021

  Harrison, C J ^a   Moorman, A V ^a   Schwab, C ^a   Carroll, A J ^b   Raetz, E A ^c   Devidas, M ^d   Strehl, S ^e   Nebral, K ^e   Harbott, J ^f   Teigler Schlegel, A ^f   Zimmerman, M ^g   Dastuge, N ^h   Baruchel, A ⁱ   Soulier, J ^j   Auclerc, M F ⁱ   Attarbaschi, A ^e   Mann, G ^e   Stark, B ^k   Cazzaniga, G ^l   Chilton, L ^a   Vandenberghe, P ^m   Forestier, E ⁿ   Haltrich, I ^o   Raimondi, S C ^p   Parihar, M ^q   Bourquin, J P ^r   Tchinda, J ^r   Haferlach, C ^s   Vora, A ^t   Hunger, S P ^u   Heerema, N A ^v   Haas, O A ^e   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e ST ANNA CHILDREN S HOSPITAL   (Austria)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h CHU PURPAN   (France)

ⁱ HÔPITAL ROBERT DEBRÉ   (France)

^j UNIVERSITÉ PARIS DIDEROT   (France)

^k SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^l UNIVERSITY OF MILANO BICOCCA   (Italy)

^m UNIVERSITY OF LEUVEN   (Belgium)

ⁿ UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^o SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^p ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^q Tata Medical Centre   (India)

^r UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^s MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^t SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^u UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^v OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

BCP ALL; chromosomal abnormalities; genetics; iAMP21; outcome; poor prognosis

Indexed keywords

PROTEIN; RB1 PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 21; CHROMOSOME 7; CHROMOSOME LOSS; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTRACHROMOSOMAL AMPLIFICATION OF CHROMOSOME 21; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899979360     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.317     Document Type: Article

References (36)

1. Harewood L, Robinson H, Harris R, Al Obaidi MJ, Jalali GR, Martineau M. et al. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: A study of 20 cases. Leukemia 2003; 17: 547-553.
2. Soulier J, Trakhtenbrot L, Najfeld V, Lipton JM, Mathew S, Avet-Loiseau H. et al. Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: An emerging molecular cytogenetic subgroup. Leukemia 2003; 17: 1679-1682.
3. Alvarez Y, Coll MD, Bastida P, Ortega JJ, Caballin MR. AML1 amplification in a child with acute lymphoblastic leukemia. Cancer Genet Cytogenet 2003; 140: 58-61.
4. Dube ID, el Solh H. An apparent tandem quadruplication of chromosome 21 in a case of childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 1986; 23: 253-256.
5. Le Coniat M, Romana SP, Berger R. Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia. Genes Chromosomes Cancer 1995; 14: 204-209.
6. Busson-Le Coniat M, Nguyen KF, Daniel MT, Bernard OA, Berger R. Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2001; 32: 244-249.
7. Baialardo EM, Felice MS, Rossi J, Barreiro C, Gallego MS. Tandem triplication and quadruplication of chromosome 21 in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 1996; 92: 43-45.
8. Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S. AML1 gene amplification: A novel finding in childhood acute lymphoblastic leukemia. Haematologica 2000; 85: 362-366.
9. Dal Cin P, Atkins L, Ford C, Ariyanayagam S, Armstrong SA, George R. et al. Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes Cancer 2001; 30: 407-409.
10. Mathew S, Rao PH, Dalton J, Downing JR, Raimondi SC. Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia. Leukemia 2001; 15: 468-472.
11. Morel F, Herry A, Le Bris MJ, Douet-Guilbert N, Le Calvez G, Marion V. et al. AML1 amplification in a case of childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 2002; 137: 142-145.
12. Penther D, Preudhomme C, Talmant P, Roumier C, Godon A, Mechinaud F. et al. Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia 2002; 16: 1131-1134.
13. Moorman AV, Robinson H, Schwab C, Richards SM, Hancock J, Mitchell CD. et al. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: A comparison of the MRC ALL97/ and UKALL2003 trials. J Clin Oncol 2013; 31: 3389-3396.
14. Heerema NA, Carroll AJ, Devidas M, Loh ML, Borowitz MJ, Gastier-Foster JM. et al. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk Children?s Oncology Group studies: A report from the Children?s Oncology Group. J Clin Oncol 2013; 31: 3397-3402.
15. Robinson HM, Broadfield ZJ, Cheung KL, Harewood L, Harris RL, Jalali GR. et al. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia 2003; 17: 2249-2250.
16. Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BE, Kinsey SE. et al. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood 2007; 109: 2327-2330.
17. Attarbaschi A, Mann G, Panzer-Grumayer R, Rottgers S, Steiner M, Konig M. et al. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: The Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. J Clin Oncol 2008; 26: 3046-3050.
18. Rand V, Parker H, Russell LJ, Schwab C, Ensor H, Irving J. et al. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. Blood 2011; 117: 6848-6855.
19. Robinson HM, Harrison CJ, Moorman AV, Chudoba I, Strefford JC. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakagefusion-bridge cycle. Genes Chromosomes Cancer 2007; 46: 318-326.
20. Strefford JC, Van Delft FW, Robinson HM, Worley H, Yiannikouris O, Selzer R. et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Proc Natl Acad Sci USA 2006; 103: 8167-8172.
21. Kuchinskaya E, Nordgren A, Heyman M, Schoumans J, Corcoran M, Staaf J. et al. Tiling-resolution array-CGH reveals the pattern of DNA copy number alterations in acute lymphoblastic leukemia with 21q amplification: The result of telomere dysfunction and breakage/fusion/breakage cycles? Leukemia 2007; 21: 1327-1330.
22. Sinclair PB, Parker H, An Q, Rand V, Ensor H, Harrison CJ. et al. Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy. Hum Mol Genet 2011; 20: 2591-2602.
23. Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 2009; 144: 147-156.
24. Harrison CJ, Haas O, Harbott J, Biondi A, Stanulla M, Trka J. et al. Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group. Br J Haematol 2010; 151: 132-142.
25. Arico M, Schrappe M, Hunger SP, Carroll WL, Conter V, Galimberti S. et al. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol 2010; 28: 4755-4761.
26. Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A. et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med 2012; 366: 1371-1381.
27. Bungaro S, Dell?Orto MC, Zangrando A, Basso D, Gorletta T, Lo Nigro L. et al. Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer 2009; 48: 22-38.
28. ISCN. An International System for Human Cytogenetic Nomenclature. In: Shaffer LG, Slovak ML, Campbell LJ (eds). S. Karger: Basel, 2009.
29. Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL. et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: A UK Cancer Cytogenetics Group Study. Br J Haematol 2005; 129: 520-530.
30. Schwab CJ, Jones LR, Morrison H, Ryan SL, Yigittop H, Schouten JP. et al. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 2010; 49: 1104-1113.
31. Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR. et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 2003; 102: 2756-2762.
32. Sutcliffe MJ, Shuster JJ, Sather HN, Camitta BM, Pullen J, Schultz KR. et al. High concordance from independent studies by the Children?s Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI standard-risk B-precursor acute lymphoblastic leukemia: A Children?s Oncology Group (COG) initiative. Leukemia 2005; 19: 734-740.
33. Haltrich I, Csoka M, Kovacs G, Torok D, Alpar D, Ottoffy G. et al. Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia. Pathol Oncol Res 2013; 19: 123-128.
34. Schwab CJ, Chilton L, Morrison H, Jones L, Al-Shehhi H, Erhorn A. et al. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: Association with cytogenetics and clinical features. Haematologica 2013; 98: 1081-1088.
35. Broadfield ZJ, Hain RD, Harrison CJ, Reza JG, McKinley M, Michalova K. et al. Complex chromosomal abnormalities in utero, 5 years before leukaemia. Br J Haematol 2004; 126: 307-312.
36. Ma SK, Wan TS, Cheuk AT, Fung LF, Chan GC, Chan SY. et al. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: A molecular cytogenetics study. Leukemia 2001; 15: 1442-1447.